Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Research reviews describe BPC-157 as a synthetic peptide derived from gastric proteins that appears to influence angiogenesis, collagen synthesis, fibroblast activity, nitric oxide pathways, and growth factor signaling
The FDA indication split and what it means for claims When the FDA approved Mounjaro in May 2022 for type 2 diabetes, the billing pathway was relatively simple
Set expectations accordingly: BPC-157 is a promising tool for knee rehabilitation, not a proven therapy
166 However, many of the included studies were rated as lower-quality evidence
BPC-157 activates the FAK-paxillin pathway, which dramatically increases fibroblast migration to injury sites
